Company Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
Equities
603707
CNE100002WP3
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.81 CNY | +2.60% | -0.65% | -7.93% |
May. 13 | NKFPharma's Unit Gets FDA's Nod to Market Eptifibatide Injection in US | MT |
May. 01 | NKFPharma Gets Nod to Register New Cancer Treatment | MT |
Business Summary
Number of employees: 1,451
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Preparation
70.5
%
| 2,458 | 66.2 % | 2,772 | 70.5 % | +12.75% |
Standard Heparin API
25.4
%
| 1,110 | 29.9 % | 997 | 25.4 % | -10.12% |
Contract Development and Manufacturing Organization and Other Products
3.9
%
| 140 | 3.8 % | 154 | 3.9 % | +9.58% |
Other Business
0.2
%
| 5 | 0.1 % | 9 | 0.2 % | +87.76% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Foreign
73.3
%
| 2,548 | 68.7 % | 2,875 | 73.3 % | +12.82% |
China
26.7
%
| 1,160 | 31.3 % | 1,048 | 26.7 % | -9.66% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yong Qun Tang
CEO | Chief Executive Officer | 49 | 03-12-31 |
Xiao Jie Qian
DFI | Director of Finance/CFO | 44 | 10-12-31 |
Xi Wei Huang
BRD | Director/Board Member | 54 | 11-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Xi Wei Huang
BRD | Director/Board Member | 54 | 11-03-31 |
Ping Shi
BRD | Director/Board Member | 62 | 19-05-15 |
Yong Qun Tang
CEO | Chief Executive Officer | 49 | 03-12-31 |
Ju Hua Xie
BRD | Director/Board Member | 73 | 08-03-30 |
Zu Qing Liu
CHM | Chairman | 74 | 11-03-02 |
Suo Qing Tian
BRD | Director/Board Member | 61 | 15-06-10 |
Yi Jin
BRD | Director/Board Member | 70 | 15-06-10 |
Xiao Ming Ma
BRD | Director/Board Member | 49 | 19-05-15 |
Guo Qing Cui
BRD | Director/Board Member | 68 | 20-05-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,616,648,684 | 432,667,997 ( 26.76 %) | 3,754,515 ( 0.2322 %) | 26.76 % |
Company contact information
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.
16 Xuefu Road Nanjing High-Tech Industrial Zone
210061, Nanjing
+86 25 8699 0701
http://www.nkf-pharma.comSector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.93% | 3.08B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- 603707 Stock
- Company Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.